Parkinson's disease It is primarily used to improve the symptoms of Parkinson's disease but does not change the course of the disease. It can take two to three weeks of treatment before benefits are seen. Each dose then begins working in about ten minutes to two hours depending on the formulation, with a duration of effect of about five hours. A formulation that can be given in an intra-intestinal pump, known as Duodopa, is being developed. Other Other uses include for dopamine-responsive dystonia (DRD) and restless legs syndrome. There is tentative evidence that it is useful in amblyopia when used with other treatments.
Carbidopa/levodopa
Donepezil
Fluorodopa
Bromperidol decanoate
Memantine
Ciladopa
Protriptyline
Rivastigmine